Dr Reddy’s launches Doxycycline capsules within the US
Dr Reddy’s Laboratories on Friday introduced the launch of Doxycycline capsules 40 mg, within the US market. The drug is a therapeutic generic equal of ORACEA (doxycycline, USP) capsules (40 mg), permitted by the US Meals and Drug Administration (USFDA), the corporate stated in a press release. “This formulation of doxycycline has not been evaluated within the remedy or prevention of infections. … Read more